Next Article in Journal
Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53
Next Article in Special Issue
Self-Reported Modifiable Risk Factors of Cardiovascular Disease among Seafarers: A Cross-Sectional Study of Prevalence and Clustering
Previous Article in Journal
Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
Previous Article in Special Issue
Prevalence of Pulmonary Hypertension in an Unselected Community-Based Population: A Retrospective Echocardiographic Study—RES-PH Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 11
Issue 6
10.3390/jpm11060508
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty

by
Milan Hromadka
1,
Zuzana Motovska
2,*,
Ota Hlinomaz
3,
Petr Kala
4,
Frantisek Tousek
5,
Jiri Jarkovsky
6,
Marketa Beranova
3,
Pavel Jansky
7,
Michal Svoboda
6,
Iveta Krepelkova
8,9,
Richard Rokyta
1,
Petr Widimsky
2 and
Michal Karpisek
8,9
1
Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen, Charles University, 304 60 Pilsen, Czech Republic
2
Cardiocentre, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic
3
First Department of Internal Medicine—Cardioangiology, International Clinical Research Center, Faculty of Medicine, Masaryk University and St. Anne’s University Hospital, 656 91 Brno, Czech Republic
4
Department of Internal Medicine and Cardiology, University Hospital and Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
5
Cardiocentre—Department of Cardiology, Regional Hospital, 370 01 Ceske Budejovice, Czech Republic
6
Institute of Biostatistics and Analyses at the Faculty of Medicine and the Faculty of Science, Masaryk University, 602 00 Brno, Czech Republic
7
Department of Anestesiology and Resuscitation, University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic
8
BioVendor—Laboratory Medicine, 621 00 Brno, Czech Republic
9
Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, 621 00 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2021, 11(6), 508; https://doi.org/10.3390/jpm11060508
Submission received: 14 April 2021 / Revised: 17 May 2021 / Accepted: 31 May 2021 / Published: 4 June 2021
(This article belongs to the Special Issue Cardiovascular Disease Prevention in the Era of Personalized Medicine)
Browse Figures
Versions Notes

Abstract

Aim. This study was designed to evaluate the relationship between microRNAs (miRNAs), miR-126-3p and miR-223-3p, as new biomarkers of platelet activation, and predicting recurrent thrombotic events after acute myocardial infarction (AMI). Methods and Results. The analysis included 598 patients randomized in the PRAGUE-18 study (ticagrelor vs. prasugrel in AMI). The measurements of miRNAs were performed by using a novel miRNA immunoassay method. The association of miRNAs with the occurrence of the ischemic endpoint (EP) (cardiovascular death, nonfatal MI, or stroke) and bleeding were analyzed. The miR-223-3p level was significantly related to an increased risk of occurrence of the ischemic EP within 30 days (odds ratio (OR) = 15.74, 95% confidence interval (CI): 2.07–119.93, p = 0.008) and one year (OR = 3.18, 95% CI: 1.40–7.19, p = 0.006), respectively. The miR-126-3p to miR-223-3p ratio was related to a decreased risk of occurrence of EP within 30 days (OR = 0.14, 95% CI: 0.03–0.61, p = 0.009) and one year (OR = 0.37, 95% CI: 0.17–0.82, p = 0.014), respectively. MiRNAs were identified as independent predictors of EP even after adjustment for confounding clinical predictors. Adding miR-223-3p and miR-126-3p to miR-223-3p ratios as predictors into the model calculating the ischemic risk significantly increased the predictive accuracy for combined ischemic EP within one year more than using only clinical ischemic risk parameters. No associations between miRNAs and bleeding complications were identified. Conclusion. The miR-223-3p and the miR-126-3p are promising independent predictors of thrombotic events and can be used for ischemic risk stratification after AMI.
Keywords: acute myocardial infarction; risk stratification; microRNA; miR-126-3P; miR-223-3p; antithrombotic therapy individualization acute myocardial infarction; risk stratification; microRNA; miR-126-3P; miR-223-3p; antithrombotic therapy individualization

Share and Cite

MDPI and ACS Style

Hromadka, M.; Motovska, Z.; Hlinomaz, O.; Kala, P.; Tousek, F.; Jarkovsky, J.; Beranova, M.; Jansky, P.; Svoboda, M.; Krepelkova, I.; et al. MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty. J. Pers. Med. 2021, 11, 508. https://doi.org/10.3390/jpm11060508

AMA Style

Hromadka M, Motovska Z, Hlinomaz O, Kala P, Tousek F, Jarkovsky J, Beranova M, Jansky P, Svoboda M, Krepelkova I, et al. MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty. Journal of Personalized Medicine. 2021; 11(6):508. https://doi.org/10.3390/jpm11060508

Chicago/Turabian Style

Hromadka, Milan, Zuzana Motovska, Ota Hlinomaz, Petr Kala, Frantisek Tousek, Jiri Jarkovsky, Marketa Beranova, Pavel Jansky, Michal Svoboda, Iveta Krepelkova, and et al. 2021. "MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty" Journal of Personalized Medicine 11, no. 6: 508. https://doi.org/10.3390/jpm11060508

APA Style

Hromadka, M., Motovska, Z., Hlinomaz, O., Kala, P., Tousek, F., Jarkovsky, J., Beranova, M., Jansky, P., Svoboda, M., Krepelkova, I., Rokyta, R., Widimsky, P., & Karpisek, M. (2021). MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty. Journal of Personalized Medicine, 11(6), 508. https://doi.org/10.3390/jpm11060508

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop